SCHEMBL29446385

SCHEMBL29446385

O=c1c2cc(Cl)ccc2n2c(=S)[nH]nc2n1CCC(F)(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24324380 1.00 PLK1 (1.00) PLK1
SCHEMBL24324384 0.88 PLK1 (1.00) PLK1
SCHEMBL29446446 0.88 PLK1 (1.00) PLK1
SCHEMBL29446480 0.85 PLK1 (1.00) PLK1
SCHEMBL24324165 0.85 PLK1 (1.00) PLK1
SCHEMBL24324192 0.84 PLK1 (1.00) PLK1
SCHEMBL29446421 0.79 PLK1 (1.00) PLK1
SCHEMBL24324729 0.79 PLK1 (1.00) PLK1
SCHEMBL24324408 0.78 PLK1 (1.00) PLK1
SCHEMBL24324373 0.77 PLK1 (1.00) PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216958-A2 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2023-08-02 EP disclosed
WO-2022067100-A2 PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-03-31 WO disclosed